Market Access News
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The December 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Five new drug products have initiated pCPA negotiations, for a total of 36 active negotiations; Eight negotiations have been completed/closed, for a total of 196 joint completed/closed negotiations; and One new drug product was added to…
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The November 30, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Four new drug products have initiated pCPA negotiations, for a total of 39 active negotiations; Eleven negotiations have been completed/closed, for a total of 188 joint completed/closed negotiations; and One new drug product was added to…
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The October 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Two new drug products have initiated pCPA negotiations, for a total of 46 active negotiations; Seven negotiations have been completed/closed, for a total of 177 joint completed/closed negotiations; and No new drug products were added to…
Toronto, October 16, 2017 – Sherry O’Quinn and Arvind Mani are very pleased to announce that Lorraine Boyle has joined the MORSE team as a Senior Advisor. Lorraine is a former registered nurse with over 25 years of experience in the Canadian public health care system and pharmaceutical and biotechnology industry. Her experience spans sales, marketing, market access, government relations and patient advocacy. Therapeutic areas of experience and expertise include nephrology,…
Executive Brief The First Nations Health Authority (FNHA), formed in 2013 in the province of British Columbia, is the first province-wide health authority of its kind in Canada. Its objective is the full transferral of programs, services, and responsibilities that were under Health Canada’s First Nations Inuit Health Branch (FNIHB) − Pacific Region’s former jurisdiction. One of the many components of the FNIHB’s programs is the Non-Insured Health…
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The September 30, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Six new drug products have initiated pCPA negotiations, for a total of 51 active negotiations; Two negotiations have been completed/closed, for a total of 170 joint completed/closed negotiations; and One new drug product was added to…
Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE LINKS, a new feature on our website. MORSE LINKS provides a comprehensive list of useful web links which can allow market access professionals to easily access frequently referenced web sites. Similar to other services offered by MORSE, LINKS has a user-friendly interface with information separated into broad categories to allow users to sort and search based…
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The August 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Six new drug products have initiated pCPA negotiations, for a total of 47 active negotiations; Five negotiations have been completed, for a total of 168 joint negotiations; and One new drug product was added to the…
The MORSE KEY: Upcoming Events and Conferences There are a number of conferences/events/deadlines that individuals in market access may be interested in for the upcoming month of September. For more details, please visit the MORSE Key Market Access Events page. Government/Agencies September 15 – CADTH Deadline for Comments on Therapeutic Review Framework September 18 – PMPRB HDAP Meeting September 20 –CDEC Meeting Associations September 11 – 2017 CAPDM MEMBER…
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The latest update as of July 31, 2017 has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO update are as follows: Seven new drug products have initiated pCPA negotiations since the last update, for a total of 46 active negotiations Three negotiations have been completed since the last update, for a total of 163 joint…
Biosimilar Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto. The theme for this conference was “Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada” which consisted of five fascinating panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the coming weeks, MORSE will be releasing summaries for each…
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Updates The latest update as of June 30, 2017 has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO update are as follows: Six new drug products have initiated pCPA negotiations since the last update, for a total of 42 active negotiations Seven negotiations have been completed since the last update, for a total of 160 joint…
The MORSE KEY: Upcoming Events and Conferences There a number of conferences and events that individuals in market access may be interested in for the upcoming month: Government/Agencies July 17 – Targeted CDEC Meeting July 27 – PMPRB Form 1 Due Associations July 13-14 - Next Generation Companion Diagnostics (Philadelphia, Pennsylvania) Professional Conferences July 8 - 12 – International Health Economics Association Boston 2017 Congress – Revolutions in the…
Topic 1: PMPRB Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held its Market Access 201 conference in Toronto. The theme for this conference was Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada which consisted of five engaging panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the coming weeks, MORSE will be releasing summaries…
Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE WIRE, a new feature on our website. MORSE WIRE is a newsfeed that provides real time, useful market access information to help stakeholders stay informed of the latest developments in the Canadian pharmaceutical reimbursement environment. MORSE WIRE has a user-friendly interface with 5 broad categories to allow users to sort and search based on keywords. The…
Contact Us
MORSE Consulting Inc.
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
Browse our Market Access News section - Page 9 of 11 - MORSE Consulting Inc.
